DIRECT ORAL ANTICOAGULANTS IN PATIENTS AFFECTED BY MAJOR CONGENITAL THROMBOPHILIA
Introduction: Thrombophilia is a condition that predisposes to a higher incidence of venous thromboembolisms (VTE), some also in atypical sites. Direct oral anticoagulants (DOACs) have proven to be effective in the treatment of deep vein thrombosis (DVT). However, their use can be sometimes challeng...
Main Authors: | alessandra serrao, benedetta lucani, davide mansour, antonietta ferretti, erminia baldacci, cristina santoro, robin foà, antonio chistolini |
---|---|
Format: | Article |
Language: | English |
Published: |
PAGEPress Publications
2019-06-01
|
Series: | Mediterranean Journal of Hematology and Infectious Diseases |
Subjects: | |
Online Access: | https://www.mjhid.org/index.php/mjhid/article/view/3960 |
Similar Items
-
Inherited thrombophilia and venous thromboembolism: testing rules in clinical practice
by: I. V. Zotova, et al.
Published: (2020-09-01) -
Thrombophilias: therapeutic employment of direct oral anticoagulants in venous hypercoagulable states
by: Federico Cacciapuoti
Published: (2020-09-01) -
Evaluation of VTE-PREDICT risk score in patients receiving low-dose DOACs for venous thromboembolism (VTE) secondary prophylaxis
by: Alessandro Laganà, et al.
Published: (2024-04-01) -
Treatment and secondary prophylaxis of venous thromboembolism with direct oral anticoagulants in patients with severe hereditary thrombophilia
by: Pasquale Madonna, et al.
Published: (2021-03-01) -
Evaluation of Antiplatelet/Anticoagulant Use and Prognosis in Primary Thrombophilia Patients with COVID-19
by: Cenk Sunu, et al.
Published: (2024-12-01)